11 Ken Griffin Graphite Bio Trades
Ken Griffin acquired 587 Thousand Graphite Bio shares worth $1.87 Million. That's 0.00% of their equity portfolio (2299th largest holding). The investor owns 1.01% of the outstanding Graphite Bio stock. The first Graphite Bio trade was made in Q2 2021. Since then Ken Griffin bought shares four more times and sold shares on six occasions. The investor's estimated purchase price is $13.3 Million, resulting in a loss of 86%.
Avg closing price
Price range
Sold 52.8% shares (-656 Thousand shares)
Q4 2023
Avg closing price
$2.36
Price range
$2.24
-
$2.66
Increased shares by 3.2% (+38.2 Thousand shares)
Q3 2023
Avg closing price
$2.48
Price range
$2.18
-
$2.77
Increased shares by 2.8% (+33.1 Thousand shares)
Q2 2023
Avg closing price
$2.85
Price range
$2.47
-
$3.38
Sold 1.6% shares (-19.2 Thousand shares)
Q1 2023
Avg closing price
$2.31
Price range
$1.85
-
$3.21
Sold 6.6% shares (-83.6 Thousand shares)
Q4 2022
Avg closing price
$3.31
Price range
$2.82
-
$3.61
Sold 3.5% shares (-45.8 Thousand shares)
Q3 2022
Avg closing price
$3.40
Price range
$2.82
-
$4.24
Increased shares by 5.2% (+65.1 Thousand shares)
Q2 2022
Avg closing price
$3.18
Price range
$2.14
-
$5.23
Increased shares by 0.8% (+9.42 Thousand shares)
Q1 2022
Avg closing price
$8.94
Price range
$5.10
-
$13.06
Sold 2.0% shares (-24.9 Thousand shares)
Q4 2021
Avg closing price
$11.84
Price range
$8.41
-
$16.71
Sold 1.4% shares (-18.1 Thousand shares)
Q3 2021
Avg closing price
$21.16
Price range
$15.81
-
$28.39
New holding (+1.29 Million shares)
Q2 2021
Avg closing price
$24.88
Price range
$18.50
-
$30.73
